Phospho-BID (S78) Antibody

What is Phospho-BID (S78) and why is it important in cell death research?

Phospho-BID (S78) refers to the BH3-interacting domain death agonist (BID) protein when phosphorylated at serine residue 78. BID is a pro-apoptotic protein that plays a crucial role in the intrinsic apoptotic pathway by inducing caspase activation and apoptosis, countering the protective effect of BCL2, and allowing the release of cytochrome c from mitochondria . The 22 kDa full-length BID can be cleaved into a major p15 and minor p13 and p11 fragments during TNF-alpha-induced apoptosis .

Phosphorylation at S78 is particularly significant because it prevents caspase-8 cleavage of BID, thus inhibiting the initiation of apoptosis . This post-translational modification serves as a regulatory checkpoint in the apoptotic cascade, making Phospho-BID (S78) an important research target for understanding cell death regulation, cellular stress responses, and potential therapeutic targets in diseases with dysregulated apoptosis.

Optimizing Western blot protocols for Phospho-BID (S78) antibody requires attention to several key factors:

• Sample preparation:

  • Use phosphatase inhibitors in lysis buffers to preserve phosphorylation states

  • Process samples quickly and keep them cold to prevent dephosphorylation

  • Consider using positive controls such as cells treated with etoposide (100 μM for 3 hrs) which has been shown to increase BID phosphorylation

• Gel electrophoresis:

  • Use 4-20% gradient SDS-PAGE gels for optimal separation

  • Load adequate protein (50-80 μg of whole cell lysate is typically sufficient)

• Transfer and blocking:

  • Ensure efficient transfer of proteins to membrane (PVDF recommended for phospho-proteins)

  • Block with 5% BSA in TBST rather than milk (milk contains phospho-proteins that may interfere)

• Antibody incubation:

  • Typical concentration for Phospho-BID (S78) antibody is around 1 μg/ml

  • Incubate overnight at 4°C for primary antibody

  • Consider using signal enhancers if signal is weak

• Detection:

  • Optimal exposure time will vary but may be around 3 minutes as seen in reference blots

  • The predicted band size for Phospho-BID (S78) is approximately 22 kDa

What controls should I use when working with Phospho-BID (S78) antibody?

Proper controls are essential for validating results with Phospho-BID (S78) antibody:

• Positive controls:

  • NIH/3T3 cells treated with etoposide (100 μM for 3 hours) have been shown to increase BID phosphorylation at S78

  • Include samples from wild-type tissues/cells alongside experimental samples

• Negative controls:

  • BID knockout (Bid-/-) cells or tissues

  • Lambda phosphatase-treated samples to remove phosphorylation

  • Secondary antibody-only controls to check for non-specific binding

• Specificity controls:

  • Pre-absorption with the immunizing phosphopeptide

  • Comparison with a total BID antibody to assess the ratio of phosphorylated to total protein

  • Use of BID mutants where S78 is replaced with alanine (S78A) to prevent phosphorylation

• Loading controls:

  • Standard housekeeping proteins (β-actin, GAPDH, etc.)

  • Total protein staining methods for normalization

These controls help ensure the specificity and reliability of Phospho-BID (S78) antibody signal in your experimental system.

What cell types express phosphorylated BID at S78?

Based on available research, phosphorylated BID at S78 has been detected in:

• Fibroblasts - NIH/3T3 mouse fibroblast cells show detectable levels, especially after etoposide treatment

• Hematopoietic stem cells - research has shown BID phosphorylation at S61 and S78 corresponds with increased ROS and respiration

• Cardiac tissue - studies have examined BID function in heart tissues, though specific S78 phosphorylation data is limited

• Myogenic progenitor cells (MPCs) - studies have examined the role of BID including its phosphorylation states

The expression and phosphorylation state may vary with cellular conditions, particularly stress conditions and DNA damage responses. It's worth noting that BID phosphorylation at S78 may be induced or enhanced by specific treatments, such as etoposide, which causes DNA damage and activates the DNA damage response pathway .

How does phosphorylation at S78 affect BID's function?

Phosphorylation of BID at S78 has several significant effects on its function:

What is the relationship between BID S78 phosphorylation and mitochondrial cristae structure/function?

Research indicates a complex relationship between BID phosphorylation and mitochondrial cristae structure/function:

This relationship suggests that studying BID phosphorylation at S78 may provide insights into mechanisms of mitochondrial adaptation and cristae remodeling in response to cellular stress.

How does Phospho-BID (S78) interact with other apoptotic pathway components?

Phospho-BID (S78) interacts with several components of the apoptotic pathway, modulating cell death signaling:

• Interaction with caspase-8:

  • Phosphorylation at S78 prevents caspase-8-mediated cleavage of BID to tBID

  • This represents a key regulatory checkpoint in the extrinsic apoptotic pathway

• BCL-2 family interactions:

  • BID contains a BH3 domain that can interact with anti-apoptotic BCL-2 family members

  • BID counters the protective effect of BCL-2

  • Phosphorylation may affect these interactions, potentially altering binding affinity or specificity

• MTCH2 (Mitochondrial carrier homolog 2) interaction:

  • Truncated Bid (tBid) residues 57–73 show strong binding to MTCH2

  • S78 is near this interaction region and phosphorylation may affect this binding

  • This interaction is relevant for tBID mitochondrial localization

• Mitochondrial membrane interactions:

  • BID contains membrane binding regions

  • The region around S78 may be involved in interactions with MTCH2 and other mitochondrial proteins

  • Phosphorylation at S78 may affect BID's interaction with mitochondrial membranes

• DNA damage response pathway:

  • S78 phosphorylation is important in the DNA damage response

  • This links BID function to cellular stress sensing mechanisms

  • May represent cross-talk between apoptotic and DNA repair pathways

What experimental approaches can verify the specificity of Phospho-BID (S78) antibody binding?

Verifying antibody specificity is critical for accurate interpretation of results. For Phospho-BID (S78) antibodies, consider these approaches:

• Genetic validation:

  • Compare signal in wild-type vs. BID knockout (Bid-/-) samples

  • Test in cells expressing BID mutants (S78A) that cannot be phosphorylated at this site

  • Rescue experiments reintroducing wild-type or mutant BID into knockout backgrounds

• Biochemical validation:

  • Peptide competition assays using the phosphopeptide immunogen

  • Lambda phosphatase treatment to remove phosphorylation

  • Compare reactivity with non-phosphorylated BID under the same conditions

  • Immunodeplete with total BID antibody then probe for phospho-signal

• Stimulus-response validation:

  • Verify increased signal after treatments known to induce BID phosphorylation (e.g., etoposide 100 μM for 3 hours)

  • Time-course analysis to demonstrate dynamic changes in phosphorylation

• Advanced analytical techniques:

  • Mass spectrometry validation of immunoprecipitated proteins

  • Epitope mapping to confirm exact binding site

  • Surface plasmon resonance (SPR) to measure binding kinetics and affinity

  • Multiplexed detection with different antibodies recognizing distinct BID epitopes

• Cross-reactivity assessment:

  • Test against related phosphopeptides to ensure specificity for S78

  • Evaluate reactivity in different species based on sequence conservation

  • Check for signal in systems with known BID expression patterns

Documentation of these validation steps enhances confidence in experimental results and should be included in research publications.

How do I design experiments to study the dynamic phosphorylation/dephosphorylation of BID at S78?

Studying the dynamic regulation of BID phosphorylation requires carefully designed temporal experiments:

• Time-course studies:

  • Treat cells with phosphorylation inducers (e.g., etoposide) and collect samples at multiple timepoints

  • Use synchronized cell populations to correlate with cell cycle phases

  • Combine with cell fractionation to track subcellular localization changes

• Kinase/phosphatase identification:

  • Use specific kinase inhibitors to identify responsible kinases

  • Perform kinase assays with recombinant BID and candidate kinases

  • Use phosphatase inhibitors to examine dephosphorylation dynamics

  • Employ siRNA/shRNA knockdown of candidate kinases/phosphatases

• Live-cell imaging approaches:

  • Develop phospho-specific FRET biosensors for BID

  • Use split luciferase complementation assays for phosphorylation-dependent interactions

  • Combine with mitochondrial markers to correlate with organelle dynamics

• Quantitative methods:

  • Quantitative Western blotting with appropriate normalization

  • Phosphoproteomics using mass spectrometry for unbiased detection

  • Enzyme-linked immunosorbent assays (ELISA) for high-throughput analysis

  • Flow cytometry with phospho-specific antibodies for single-cell analysis

• Correlation with functional outcomes:

  • Simultaneous measurement of apoptotic markers

  • Assessment of mitochondrial parameters (membrane potential, ROS, respiration)

  • Measurement of caspase activation in parallel with phosphorylation state

What are the best methods to study Phospho-BID (S78) in primary cells versus cell lines?

Studying Phospho-BID (S78) in different cellular systems requires tailored approaches:

• Primary cells vs. cell lines considerations:

• Recommended methods for primary cells:

  • Flow cytometry for phospho-protein detection at single-cell level

  • Immunofluorescence with high-sensitivity detection systems

  • Proximity ligation assay (PLA) for detecting protein interactions

  • ELISA with signal amplification for quantitative analysis

  • Magnetic bead-based IP for efficient protein capture from limited samples

  • Analysis of tissues like heart samples as described in studies examining BID function

• Recommended methods for cell lines:

  • Standard Western blotting protocols as demonstrated with NIH/3T3 cells

  • Stable expression of tagged BID constructs for easier detection

  • CRISPR/Cas9 gene editing for generating BID mutations

  • High-throughput screening approaches

  • Live-cell imaging with fluorescent reporters

• Optimizations for primary cells:

  • Minimize sample handling to prevent loss and degradation

  • Use carrier proteins in precipitation protocols

  • Consider phosphatase inhibitor cocktails optimized for tissue-specific phosphatases

  • Employ signal amplification methods for low-abundance proteins

  • Pooling samples may be necessary for some applications

How can I use Phospho-BID (S78) antibodies in combination with other markers to analyze mitochondrial dynamics?

Combining Phospho-BID (S78) detection with other mitochondrial markers enables comprehensive analysis of mitochondrial dynamics:

• Multiplexed immunofluorescence approaches:

  • Co-stain for Phospho-BID (S78) with mitochondrial markers (TOM20, COXIV, MitoTracker)

  • Include markers for mitochondrial morphology (OPA1, DRP1, MFN1/2)

  • Add markers for apoptotic events (cytochrome c, active caspases)

  • Use different fluorophores with minimal spectral overlap

  • Analyze with confocal or super-resolution microscopy

• Flow cytometry panels:

  • Combine Phospho-BID (S78) antibody with:

    • TMRE or JC-1 for mitochondrial membrane potential

    • MitoSOX for mitochondrial ROS

    • MitoTracker Green for mitochondrial mass

    • Annexin V/PI for apoptosis detection

  • Use compensation controls to correct for spectral overlap

  • Consider fixation-compatible dyes if detecting intracellular phospho-proteins

• Biochemical fractionation approaches:

  • Isolate mitochondrial, cytosolic, and nuclear fractions

  • Probe each fraction for Phospho-BID (S78)

  • Simultaneously assess mitochondrial proteins (e.g., VDAC, cytochrome c)

  • Use markers to confirm fraction purity (e.g., tubulin for cytosol, histone H3 for nucleus)

• Functional assays:

  • Oxygen consumption measurement (as shown in studies with Bid-/- vs. Bid+/+ tissues)

  • ATP production assays alongside Phospho-BID detection

  • Mitochondrial permeability transition pore (MPTP) opening assays

  • Measurement of cristae density and morphology by electron microscopy

Example experimental design from research showed that Bid-/- fibers had decreased respiratory function and ATP production compared to Bid+/+ fibers, demonstrating how BID affects mitochondrial respiration .